AI Earns "Co-Scientist" Status: From Hypothesis Generation to In Vivo Tests

On March 16, 2026, Nature Medicine published a massive review documenting a tectonic shift in R&D. AI models have definitively moved beyond conversational chatbots and into the status of full-fledged "co-scientists."

The authors of the paper argue that algorithms no longer simply parse scientific literature but are capable of synthesizing new, non-obvious biomedical hypotheses. Moreover, these AI-generated ideas have already moved to the physical testing stage: they are being tested on organoids, animal models, and even in early-phase clinical trials. This radically accelerates the Drug Discovery cycle, relieving the cognitive load on research teams and eliminating human bias when searching for correlations in molecular biology.

Source: Nature Medicine